Skip to main content
Neuro-Oncology Advances logoLink to Neuro-Oncology Advances
. 2023 Mar 13;5(1):vdad019. doi: 10.1093/noajnl/vdad019

Corrigendum to: Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies

PMCID: PMC10010464  PMID: 36923271

This is a corrigendum to: Nicholas Mikolajewicz, Shahbaz Khan, Mara Trifoi, Anna Skakdoub, Vladmir Ignatchenko, Sheila Mansouri, Jeffrey Zuccato, Brad E Zacharia, Michael Glantz, Gelareh Zadeh, Jason Moffat, Thomas Kislinger, Alireza Mansouri, Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac161, https://doi.org/10.1093/noajnl/vdac161

In the originally published version of this manuscript, the surname of author Jeffrey Zuccato was incorrectly given as Zuccatto.

This error has now been corrected.


Articles from Neuro-Oncology Advances are provided here courtesy of Oxford University Press

RESOURCES